Download as PDF, PPTX
Uploaded byChen Yang
Molnupiravir and Favipiravir-Introduction to COVID-19, Prevention and Treatment
This document provides an overview of COVID-19, including its background, mechanisms, prevention, and treatment. It discusses the timeline and evolution of COVID-19, as well as its pathogenesis and symptoms. Regarding prevention, it classifies and compares different vaccines, noting advantages of mRNA vaccines. For treatment, it discusses potential targets in the virus life cycle and candidate medicines like favipiravir and molnupiravir that inhibit COVID-19 replication.
Molnupiravir and Favipiravir-Introduction to COVID-19, Prevention and Treatment
- 1. Introduction to COVID-19 Preventionand Treatment Boten Elemento Pharma w w w . e l e m e n t o p h a r m a . c o m
- 2. Index 1 2 3 4 Background Introduction about theCOVID-19, epidemics, world infection Mechanism Virus life cycle and disease mechanism Prevention Classfication and Comparison of Vaccines Treatment Targets and Medicine
- 3. Our Products-Favipiravir andMolnupiravir
- 4. PART 01 Background Introduction aboutthe COVID-19, epidemics, world infection
- 5. Timeline of COVID-19progress
- 6. COVID-19 Phylogenic Treeand Evolution
- 7.
- 8. PART 02 Mechanism Virus lifecycle and disease mechanism
- 9.
- 10. Syndromes and Symptomsof COVID-19
- 11. Virus Structure Patternand Their Function
- 12.
- 13. Virus Entry, SProtein and ACE2
- 14. Distribution of ACE2Gene in the Human Body
- 15. Distribution of ACE2and Symptoms of Organs
- 16. PART 03 Prevention Classfication andComparison of Vaccines
- 17. Difference between Preventionand Treatment Prevention The majority of the target is S protein, that is on the surface of the virus. The surface protein is used for the immune memory generation Treatment Treatment can use different targets of virus. As long as the treatment method could disturb any step of the virus life cycle, entry, rapilication, assmbly or egress. Treatment Prevention
- 18. Virus Structure Patternand Their Function
- 19.
- 20. Immunity Response ofVaccines Generated
- 21. Vaccines Comparsion Effciencyand Safety Advantages for mRNA Vaccine: Fast, Adaptable ,Safe
- 22.
- 23. PART 04 Treatment Targets andMedicine
- 24. Potential Target AndCandidate Medicine
- 25. Molnupiravir Inhibits COVID-19Replication
- 26. Favipiravir Inhibits COVID-19Replication
- 27. 把 温 暖送 给 父 母 , 让 情 爱 陪 伴 老 人 THANK YOU FOR LISTENING Facebook https://www.facebook.com/elementopharma WhatsApp +856-20-57881987 Twitter https://twitter.com/elementopharma Instagram https://www.instagram.com/elementopharma/ Line elementopharma Kakao Talk elementopharma WeChat elementopharma TikTok https://www.tiktok.com/@elementopharma VK vk.com/elementopharma Telegram elementopharma Pinterest https://www.pinterest.com/elementopharma/